2022
DOI: 10.1097/md.0000000000029049
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, and biological evaluation of histone deacetylase inhibitor with novel salicylamide zinc binding group

Abstract: Introduction: Histone deacetylases (HDACs) have emerged as important therapeutic targets for various diseases, such as cancer and neurological disorders. Although a majority of HDAC inhibitors use hydroxamic acids as zinc binding groups, hydroxamic acid zinc-binding groups suffer from poor bioavailability and nonspecific metal-binding properties, necessitating a new zinc-binding group. Salicylic acid and its derivatives, well-known for their therapeutic value, have also been reported to chelate zi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…We proffer a theoretical synthetic route for compound M05 using intermediate XIV as the key substrate. The initial strategy to obtain XIV consists of two steps [ 155 ]. Firstly, the coupling reaction of acid derivative XII with o -(tetrahydro-2 H -pyran-2-yl) hydroxylamine (NH 2 OTHP) in DMF with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N,N -diisopropylethylamine (DIPEA) will provide derivative XIII.…”
Section: Resultsmentioning
confidence: 99%
“…We proffer a theoretical synthetic route for compound M05 using intermediate XIV as the key substrate. The initial strategy to obtain XIV consists of two steps [ 155 ]. Firstly, the coupling reaction of acid derivative XII with o -(tetrahydro-2 H -pyran-2-yl) hydroxylamine (NH 2 OTHP) in DMF with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N,N -diisopropylethylamine (DIPEA) will provide derivative XIII.…”
Section: Resultsmentioning
confidence: 99%